Renaissance Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676K | Sell |
|
|||||
|
2025
Q1 | $831K | Sell |
|
|||||
|
2024
Q4 | $1.28M | Sell |
|
|||||
|
2024
Q3 | $1.5M | Sell |
|
|||||
|
2024
Q2 | $34.4M | Sell |
|
|||||
|
2024
Q1 | $32.5M | Sell |
|
|||||
|
2023
Q4 | $36.2M | Sell |
|
|||||
|
2023
Q3 | $32.1M | Sell |
|
|||||
|
2023
Q2 | $33.1M | Sell |
|
|||||
|
2023
Q1 | $30.1M | Buy |
|
|||||
|
2022
Q4 | $27.6M | Sell |
|
|||||
|
2022
Q3 | $27.9M | Sell |
|
|||||
|
2022
Q2 | $29.9M | Sell |
|
|||||
|
2022
Q1 | $35.3M | Buy |
|
|||||
|
2021
Q4 | $27.5M | Buy |
|
|||||
|
2021
Q3 | $21.6M | Buy |
|
|||||
|
2021
Q2 | $20.5M | Sell |
|
|||||
|
2021
Q1 | $22.9M | Buy |
|
|||||
|
2020
Q4 | $19.6M | Buy |
|
|||||
|
2020
Q3 | $21.5M | Sell |
|
|||||
|
2020
Q2 | $23.1M | Buy |
|